144 related articles for article (PubMed ID: 17708571)
21. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of annexin A7 gene and protein induces the apotosis and decreases the invasion, migration of the hepatocarcinoma cell line.
Huang Y; Wang Q; Du Y; Bai L; Jin F; Zhang J; Fan S; Wang H; Song L; Gao Y; Wang X; Tang J
Biomed Pharmacother; 2014 Sep; 68(7):819-24. PubMed ID: 25070395
[TBL] [Abstract][Full Text] [Related]
23. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
[TBL] [Abstract][Full Text] [Related]
24. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
[TBL] [Abstract][Full Text] [Related]
25. Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T; Ninck C; Bloch M; Mirlacher M; Koivisto PA; Helin HJ; Mihatsch MJ; Gasser TC; Bubendorf L
Int J Cancer; 2005 Feb; 113(4):619-28. PubMed ID: 15472903
[TBL] [Abstract][Full Text] [Related]
26. [Expression of annexin A7 and its clinical significance in gastric carcinoma].
Yuan HF; Li Y; Tan BB; Zhao Q; Fan LQ; Ye WH
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):346-50. PubMed ID: 27188606
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Annexin A7, Galectin-3 and Gelsolin as possible biomarkers of hepatocarcinoma lymphatic metastasis.
Wang X; Yuegao ; Bai L; Ibrahim MM; Ma W; Zhang J; Huang Y; Wang B; Song L; Tang J
Biomed Pharmacother; 2014 Apr; 68(3):259-65. PubMed ID: 24529848
[TBL] [Abstract][Full Text] [Related]
28. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of ANXA7 decreases metastatic potential of human hepatocellular carcinoma cells in vitro.
Ibrahim MM; Sun MZ; Huang Y; Jun M; Jin Y; Yue D; Jiasheng W; Zhang J; Qazi AS; Sagoe K; Tang J
Biomed Pharmacother; 2013 May; 67(4):285-91. PubMed ID: 23582794
[TBL] [Abstract][Full Text] [Related]
30. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
31. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
32. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
35. A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.
Grifantini R; Pagani M; Pierleoni A; Grandi A; Parri M; Campagnoli S; Pileri P; Cattaneo D; Canidio E; Pontillo A; De Camilli E; Bresciani A; Marinoni F; Pedrazzoli E; Nogarotto R; Abrignani S; Viale G; Sarmientos P; Grandi G
J Proteomics; 2011 Dec; 75(2):532-47. PubMed ID: 21920474
[TBL] [Abstract][Full Text] [Related]
36. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice.
Banach-Petrosky W; Jessen WJ; Ouyang X; Gao H; Rao J; Quinn J; Aronow BJ; Abate-Shen C
Cancer Res; 2007 Oct; 67(19):9089-96. PubMed ID: 17909013
[TBL] [Abstract][Full Text] [Related]
37. Expression of NKX3.1 in normal and malignant tissues.
Gelmann EP; Bowen C; Bubendorf L
Prostate; 2003 May; 55(2):111-7. PubMed ID: 12661036
[TBL] [Abstract][Full Text] [Related]
38. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases.
Fleischmann A; Rocha C; Schobinger S; Seiler R; Wiese B; Thalmann GN
Prostate; 2011 Apr; 71(5):453-60. PubMed ID: 20878946
[TBL] [Abstract][Full Text] [Related]
40. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.
Abate-Shen C; Banach-Petrosky WA; Sun X; Economides KD; Desai N; Gregg JP; Borowsky AD; Cardiff RD; Shen MM
Cancer Res; 2003 Jul; 63(14):3886-90. PubMed ID: 12873978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
